28th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers
Monday, September 30 – Thursday, October 3 2013
9:00 am – 5:00 pm
This event was posted by Partners HealthCare System, Inc.
Location: Hotel Marlowe - Cambridge MA
Upon completion of this course participants will be able to:
- Evaluate molecularly targeted agents approved or currently in clinical development for cancer treatment.
- Assess relevant, state-of-the-art or translational pre-clinical models of cancer therapy.
- Recognize the steps and determinants of the metastatic process of cancer.
- Compare correlative studies of biomarkers and their response and resistance to targeted therapies in cancer patients.
- Analyze state of the art imaging techniques and their applications in pre-clinical and clinical studies will be taught.
Our 28th Annual Tumor Course will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, angiogenesis, metastasis and targeted therapies. Our internationally recognized faculty will present their latest findings from their clinics and laboratories. The goal is to highlight key gaps in our present knowledge of cancer and outline future directions for research at the bench, in the clinic, and in drug development.
The course will continue its four-day live lecture format. The faculty will encourage an open discussion and will provide critical comments on the challenges and the future opportunities in research on cancer and in establishment of novel therapy approaches and biomarkers to guide treatment.
The aim of this course is to analyze and synthesize the most up-to-date findings. Our faculty will present valuable information in a systematic and comprehensive framework, along with a critical review of various measurement techniques. This course is dedicated to helping improve clinical translation of this knowledge for improved cancer treatment.